Bloodstream infection is a life-threatening systemic infection. Timely and accurate identification of bloodstream infection pathogens and susceptibility testing are crucial for optimizing antimicrobial therapy, improving cure rates, and enhancing patient outcomes. Blood culture is the gold standard for diagnosing bloodstream infections. The use of antimicrobial agents, the omission of fastidious and slow-growing bacteria, non-standard blood collection volumes, improper timing of blood collection, and delayed of entry are factors that affect the positivity rate and time to detection (TTD), causing significant challenges for clinical microbiologists.

Interference from antimicrobial agents

A brand-new generation of blood culture bottles

Missed detection of slow-growing bacteria

Slow growth solution

Management process is complex and cumbersome

Comprehensive solution for process management

Mindray's independently developed new-generation automatic microbial culture system drives innovation in reagents, algorithms, and software. This advanced system enables rapid detection of positive results in a short timeframe, facilitating the swift diagnosis of bloodstream infections while optimizing workflow in clinical microbiology labs.